Additionally, we demonstrated that 6βCHV treatment induces apoptosis in bCSCs through caspase 3/7 activation, confirming its potential as an anti-cancer agent capable of targeting the stem-like properties of these cells. The gene discussed is CASP3; the disease is cancer.